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The level of endogenous photosensitiser, protoporphy-
rin IX (PPIX), can be enhanced in the cells by 5-
aminolevulinic acid (ALA). We investigated the effect
of critical parameters such as growth state of the cells
and availability of intracellular iron in modulating
the level of PPIX, in human primary cultured skin
fibroblasts (FEK4) maintained either in exponentially
growing or growth-arrested phase, following treat-
ment with ALA. The addition of ALA to exponentially
growing cells increased the level of PPIX 6-fold relative
to control cells; however, in growth-arrested cells the
same treatment increased the level of PPIX up to 34-
fold. The simultaneous addition of the hydrophilic
iron-chelator Desferal with ALA, boosted the level of
PPIX up to 47-fold in growing cells and up to 42-fold
in growth-arrested cells, suggesting that iron is limiting
Protoporphyrin IX (PPIX), an endogenous photosen-sitiser, is the direct precursor of heme in mammaliancells. This natural photodynamic agent is the crucialchromophore involved in the photosensitization drivenby 5-aminolevulinic acid (ALA) supplementation. The
addition of exogenous ALA to cells bypasses the negative feedback
control of heme biosynthesis, leading to intracellular accumulation
of photosensitizing concentrations of PPIX. The resulting photosen-
sitization provides a basis for using ALA-induced PPIX for photo-
dynamic therapy (PDT) of cancer (Kennedy et al, 1990; Wolf and
Kerl, 1991; Peng et al, 1992). Recently Hua et al (1995) have
investigated the mechanism(s) of ALA-based PDT in order to
evaluate its relative effectiveness in controlling tumor growth in vivo.
They have demonstrated that PPIX is the predominant porphyrin
species formed in tumors after ALA administration.
Although an understanding of heme biosynthesis has helped to
advance the field of ALA/PDT, the mechanism of the preferential
accumulation of PPIX in tumor cells after ALA treatment is still
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under the latter conditions. The strict dependence of
PPIX enhancement on free available iron levels was
examined by the level of activation of iron regulatory
protein in band shift assays. This analysis revealed that
the basal level of iron regulatory protein in growth-
arrested cells was 6-fold higher than in growing cells,
reflecting the influence of the free available iron pool
in exponentially growing cells. Interestingly, the same
ratio was found between the basal level concentration
of PPIX in growing and growth-arrested cells. We
propose that iron regulatory protein activation could
serve as a marker for developing photodynamic ther-
apy protocols because it identifies cells and tissues with
a propensity to accumulate PPIX and it is therefore
likely to predict the effectiveness of such therapies. Key
words: iron/iron-chelator/PDT/UVA. J Invest Dermatol
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unknown. In some studies, a correlation between cell proliferation
rates and PPIX synthesis has been suggested (Rebeiz et al, 1992;
Malik et al, 1989), but these studies lack an explicitly stated
proliferation rate. The accumulation of PPIX in the cells is not
only influenced by the ratio of ALA conversion to PPIX, but is
also related to the ferrochelatase-mediated insertion of ferrous iron
into the porphyrin macrocycle to produce the heme molecule. It
has been shown that differences in available iron in cells may
influence the patterns of PPIX accumulation in vivo (Licznerski
et al, 1993); however, the selective accumulation of PPIX in some
malignant cells is attributed to their low ferrochelatase activity
(Schoenfeld et al, 1988; El-Sharabasy et al, 1992). In some ALA/
PDT studies, iron-chelators have been used to enhance the PPIX
level by decreasing the amount of available iron in the cells
(Licznerski et al, 1993; Hanania and Malik, 1992; He et al, 1993;
Iinuma et al, 1994; Berg et al, 1996). A clear model does not
emerge from these studies, probably because of the difficulty in
comparing the results obtained from tumors of diverse origin,
where the rate of PPIX accumulation is dictated by a varying
combination of specific cellular and tissue characteristics. There is
a strong requirement to find cell and tissue markers that will
indicate which tumors are suitable for ALA/PDT, because the
effectiveness of ALA in inducing PPIX in the cells is cell-, tissue-
and organ-specific (Kennedy et al, 1990). Recently, Rittenhouse-
Diakun et al (1995) have used the transferrin receptors (TfR, also
designated CD71) of the cells as a marker for the intracellular level
of iron in ALA/PDT. They have shown that some activated normal
and malignant lymphocytes that have increased CD71 expression,
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can be identified as cells highly susceptible to ALA/PDT and
therefore could serve as a PDT target. This marker may have
limited usefulness, however, because in some malignant cell lines
the presence of elevated TfR expression is unrelated to internal
iron stores (Neckers, 1991). Direct measurement of intracellular
levels of free iron is extremely difficult. The protein central to iron
homeostasis in the cell is the iron regulatory protein (IRP), which
when activated in response to low iron levels binds to iron
responsive elements (IRE) of ferritin and TfR mRNA. This results
in either an inhibition of ferritin synthesis or an increase in the
stability of the TfR mRNA, both of which will lead to increased
levels of free intracellular iron. An extremely sensitive estimate of
free iron levels can be made using IRP/IRE bandshift assays.
In this study, we examined the accumulation of PPIX in the
primary fibroblast FEK4 cell line maintained in both a growing
(full serum) and a growth-arrested (several days in low serum) state.
The correlation between the enhancement of PPIX levels and the
level of the free iron pool in the cells after various treatments was
monitored by the level of activation of IRP in bandshift assays.
MATERIALS AND METHODS
All biochemicals were from Sigma (Poole, U.K.) except where indicated.
Cell culture The normal human skin fibroblast cell line (FEK4) was
cultured in Earle’s modified minimal essential medium (EMEM; Life
Technologies, Paisley, Scotland) supplemented with 15% fetal calf serum
(Seromed, Germany), L-glutamine (Life Technologies), sodium bicarbonate
(Life Technologies), penicillin, and streptomycin (Life Technologies). For
growing-phase experiments, cells were grown to 80% confluency in 15 cm
dishes for 3 d. At day 3, each dish contained µ1 3 106 fibroblasts. For
experiments with growth-arrested cells, cells were first cultured as described
above and then the 15% fetal calf serum conditioned media was replaced
by fresh EMEM containing 0.5% fetal calf serum and incubated for 10
more days. The cells were counted each day of incubation either in full
serum for 3 d (15% fetal calf serum) or in low serum for 10 d (0.5% fetal
calf serum). The results (not shown) revealed that in full serum conditions,
the number of cells doubled each 22 h until day 3 (80% confluency) and,
when incubated until day 4 (100% confluency), cells stopped dividing.
After changing the full serum media at day 3 for media containing 0.5%
fetal calf serum, cells stopped dividing and the number of cells stayed
constant for the next 10 d. For this study we refer to cells incubated for
3 d in full serum media as growing cells and as growth-arrested whenever
they were incubated for 10 d in 0.5% fetal calf serum. Fibroblasts were
passaged by trypsinization once a week and used for experiments between
passages 10 and 14.
Induction of PPIX biosynthesis Monolayers of cultured fibroblasts in
growing (day 3, 80% confluence) or growth-arrested phase (day 10 in
0.5% fetal calf serum EMEM) were treated for 18 h in their respective
conditioned media supplemented with ALA alone or combined with
Desferal (Ciba-Geigy, Basel, Switzerland). The concentration of 100 µM
was chosen for ALA and Desferal (see Results).
Determination of porphyrin levels After 18 h incubation in the dark
with ALA or ALA plus Desferal in conditioned media, porphyrins were
extracted out of cells according to Shoenfeld et al (1994). The porphyrin
extracts were then diluted 1:30 in 1.5N HCl and the fluorescence was
measured using a Perkin-Elmer LS5 luminescence spectrometer (404 nm
excitation and detection at 604 nm). Concentration of porphyrins was
determined using commercial PPIX as the standard and then normalized
for cell number. The level of PPIX was also measured in the conditioned
media of the growing and growth-arrested cells after addition of ALA
alone or combined with chelators according to Fukuda et al (1993). The
results (not shown) revealed minor traces of PPIX (less than 2% of
accumulated PPIX in the cells) in media from growing cells and no traces
in media from growth-arrested cells. This is probably because ALA/chelator
treatments were always performed in conditioned media rather than fresh
serum-containing media. Nevertheless this amount is included in the values
given for PPIX accumulation in growing cells.
Determination of porphyrin levels in growing cells pretreated
with Desferal In order to verify that iron-chelation prior to ALA
administration increases the level of PPIX, cells in the growing state (day
3, 80% confluent) were pretreated with Desferal prior to ALA treatment:
Cells were first incubated for 6 or 15 h with 100 µM Desferal and then
washed twice with phosphate-buffered saline (PBS, Oxoid, Basingstoke,
U.K.). After addition of conditioned media containing 100 µM ALA, the
cells were incubated for 18 h in the dark and porphyrins were extracted
out of cells. The fluorescence was measured by a spectrofluorimeter.
Determination of porphyrin levels in growth-arrested cells pre-
treated with Fe-citrate To test if the addition of free iron to the
growth-arrested cells converts the accumulated PPIX to heme and therefore
decreases the level of PPIX in these cells, we performed the following
experiment: Cells growth-arrested for 10 d were pretreated for 6 or 15 h
with 1, 10, and 50 µM Fe-citrate. For Fe-citrate treatments, a fresh 1 mM
stock solution of Fe-citrate was prepared each time by equimolar mixing
of 1 mM Na3 citrate and 1 mM FeCl3 solutions. After several rinses with
PBS, the cells were incubated for 18 h under dark conditions in conditioned
media supplemented with ALA (100 µM). The porphyrins were then
extracted out of cells and their fluorescence was measured by a spectrofluor-
imeter.
Determination of the basal level of porphyrins in FEK4 cells in the
growing and growth-arrested state In order to follow changes in the
basal level of porphyrins in growing and growth-arrested cells, the following
time course experiment was designed: The Porphyrins of cells were either
extracted in the growing state (in 15% fetal calf serum EMEM) at day 3
(G3, 80% confluency) or every 4 d in the growth-arrested state (in 0.5%
fetal calf serum EMEM) till day 10 (A2, A6, A10). The level of porphyrins
was determined by a spectrofluorimeter.
Determination of the level of free iron in the cells by RNA-protein
bandshift assay In order to verify that differences in available iron under
the above conditions are responsible for the variation of PPIX accumulation,
we employed the RNA-bandshift assay in which the level of iron is
monitored by the formation of complexes between IRP and the IRE of
ferritin mRNA. For the time-course experiments, the cytoplasmic extracts
were prepared at 4°C either from growing cells in day 3 (G3, 80%
confluency), or every 4 d from growth-arrested cells (A2, A6, and A10)
according to Mu¨llner et al (1989). The 32P-labeled RNA was transcribed
in vitro from 1 µg of linearised (BamHI-cleaved) plasmid pGem-3Zf(1),
containing the wild-type IRE (clone 42, Henderson et al, 1994) from the
59-untranslated region of human ferritin heavy chain mRNA, as described
previously (Henderson et al, 1994). RNA-protein complexes were analyzed
according to Mu¨llner et al (1989). The results were scanned with a
PhosphorImager and quantitated with software Image Quant 3.3 (Molecular
Dynamics, Sunyvale, CA).
UVA irradiation A Uvasun lamp (Mutzhas, Munich, Germany) was
used as a source of broad spectrum UVA irradiation at fluences of 10, 20,
and 50 kJ per m2, which were measured using an IL1700 radiometer
(International Light, Newbury, MA). Irradiation was done at 25°C. Prior
to irradiation, the media was removed and retained and the fibroblasts
were covered with Ca21/Mg21 (0.01% each)-enriched PBS as described
previously (Keyse and Tyrrell, 1989).
Test for phototoxicity
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) assay
Cultures of growing and growth-arrested FEK4 cells in 35 mm plates were
first treated with ALA (6 iron-chelator for 18 h, under dark conditions),
and then irradiated with UVA at the indicated doses. The dark controls
were prepared under the same conditions, except that they were not
irradiated. After irradiation, the original media was added back to the
fibroblasts and the cells were incubated from 4 to 28 h. At the end of
incubation, the media was removed and the cells were covered with 1 ml
serum-free media containing 100 µl of 5 mg MTT (3-[4,5-Dimethylthiazol-
2-yl]-2,5-diphenyl-tetrazolium bromide) per ml. After 3 h, the MTT
solution was removed and 1 ml of dimethylsulfoxide was added to the
cells. Next, 100 µl of the solution was transferred into a 96 well plate and
the plate was read on a ELISA-reader EAR 400 (SLT-Labinstruments,
Vienna, Austria) using a 577 nm bandpass filter. The percentage of viable
cells was calculated by comparing the absorbency of treated versus nontreated
cell wells.
Clone forming ability assay In order to confirm the results obtained by
MTT, cultures of growing and growth-arrested FEK4 cells in 10 cm plates
were first treated for 18 h with ALA 6 Desferal and then irradiated with
UVA at indicated doses. After trypsinization, cells were diluted at 300–
3000 cells per 10 cm plate and kept at 37°C under dark conditions for
14 d. Cells were then stained with crystal-violet in 1% methanol. The
fraction of surviving cells was determined relative to the sham-exposed
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Table I. Modulation of PPIX levels following treatment of
growing and growth-arrested (arrested) cells with ALA
F/– Desferal
Drug Concentration Incubation time pmoles PPIX per
(µM) (h) 107 cellsa
Control/growing – 18 4.8 6 1
Control/arrested – 18 27.3 6 3
Desferal/growing 100 18 5.7 6 1
Desferal/arrested 100 18 28.4 6 2
ALA/growing 100 18 31.5 6 2
ALA/arrested 100 18 935.2 6 60
ALA 1 Desferal/ 100 18 225.8 6 12
growing
ALA 1 Desferal/ 100 18 1158.9 6 105
arrested
aPPIX values are means 6 SEM, n 5 8.
levels, which were normalized to 100%. The plating efficiency of the
sham-exposed population was 72% 6 5% under these conditions.
RESULTS
Modulation of porphyrin biosynthesis in growing and
growth-arrested cells by ALA Stimulation of porphyrin bio-
synthesis in growing and growth-arrested cells was initially achieved
by incubation of cells for various time (4–36 h) with different
concentrations of ALA alone or combined with the iron-chelator
Desferal. A comparison was made between two fluorimetric assays
of spectrofluorimetry (using commercial PPIX as a calibration
marker) and high performance liquid chromatography analysis in
order to characterize the porphyrins extracted from the cells. These
analyses (not shown) revealed a concentration of 100 µM to be
optimal (low toxicity and high efficiency) for both ALA and
Desferal. The incubation time of 18 h was chosen to measure the
PPIX level, because by 24 h this level was decreasing gradually.
High performance liquid chromatography analysis of cells treated
with ALA alone or combined with Desferal revealed that the
overall porphyrin produced in the treated cells consisted of PPIX
and therefore the porphyrin fluorescence in our extracts could be
attributed to PPIX (data not shown).
Table I shows the accumulation (pmoles) of PPIX in 107
growing and growth-arrested cells after treatment with ALA alone,
Desferal alone, or their combination for 18 h. The treatment of
growing cells with ALA alone increased the level of PPIX only 6-
fold over untreated controls, whereas in growth-arrested cells the
same treatment boosted the level of PPIX up to 34-fold over
controls. The comparison of the basal level of PPIX in untreated
growing and growth-arrested controls revealed that this level was
6-fold higher in growth-arrested cells. This basal level was boosted
up to 935 pmoles in 107 growth-arrested cells with ALA, whereas
in growing cells this level reached only a value of 31. PPIX
accumulation is inversely dependent on available intracellular iron,
which is required for the conversion of PPIX to heme. Upon ALA
treatment, the transient accumulation of PPIX will increase if the
rate of conversion of ALA to PPIX is greater than that of PPIX to
heme. The latter conversion also involves the ferrochelatase enzyme
that adds iron to PPIX to produce the heme molecule. In order
to verify the role of intracellular iron on PPIX accumulation in
growing and growth-arrested FEK4 cells, we combined the ALA
treatment with the iron-chelator Desferal for 18 h. The results
(Table I) showed that simultaneous treatment of growing cells
with ALA and Desferal was capable of boosting the level of PPIX
up to 47-fold above control values, whereas in growth-arrested
cells the same treatment resulted in a moderate increase from 34-
(ALA alone) to 42-fold above the corresponding control values.
Furthermore the treatment of growing and growth-arrested cells
with Desferal, but no exogenous ALA, only slightly (up to 1.3-
fold over controls) modulates the level of PPIX over corresponding
control values, suggesting that iron starvation alone is not sufficient
to boost the level of PPIX in the cells. Because the treatment of
growth-arrested cells with ALA/chelator only moderately increased
the PPIX level over that seen with ALA alone and the basal level
of PPIX was higher in growth-arrested cells compared with growing
cells, we conclude either that the ferrochelatase activity is very low
in nondividing cells or that, in the growth-arrested state, the iron
available in cells for conversion of PPIX to heme is limited.
Pre-treatment of growing FEK4 cells with Desferal prior to
ALA treatment In order to distinguish between the possibilities
mentioned above, we attempted to mimic the situation arising in
growth-arrested cells, by generating conditions where iron is at a
low level in growing cells. For this purpose we incubated the
growing FEK4 cells with Desferal for either 6 or 15 h, prior to
ALA treatment for 18 h. This was followed by spectrofluorimetric
measurement of PPIX levels. The results (Fig 1a) showed that
addition of Desferal alone to the cells for 6 or 15 h did not
significantly increase the level of PPIX (0.98–1.3-fold over
untreated control, respectively). When this treatment was followed
by ALA administration for 18 h, however, the level of PPIX
increased up to 87-fold over controls. The treatment with ALA
alone for 18 h increased this level only six times and simultaneous
treatment of growing cells with ALA and Desferal for the same
period of time increased this level only up to 47-fold (results
consistent with previous observations, Table I). These results
suggested that the level of accumulation of PPIX in cells, following
ALA induction, is directly related to the levels of available iron.
Pre-treatment of growth-arrested FEK4 cells with different
concentrations of Fe-citrate prior to ALA administration
We then tried the inverse procedure to mimic the situation arising
in growing cells by treating the growth-arrested cells with various
concentrations of Fe-citrate (1, 10, and 50 µM) for 15 h prior to
ALA administration. The results (Fig 1b) showed that the addition
of Fe-citrate alone for 15 h slightly modulated the basal level of
PPIX in growth-arrested cells, where it was decreased to a 0.5-
fold control value. Consistent with previous results (see Table I),
addition of ALA alone increased this level up to 34-fold above
control values. When Fe-citrate treatment was followed by ALA
treatment, however, the level of accumulated PPIX decreased
gradually and in a dose-dependent manner up to 5-fold over
nontreated controls. The fact that addition of Fe-citrate decreased
the level of PPIX in growth-arrested cells following ALA treatment,
suggested that a lack of iron rather than low ferrochelatase activity
was responsible for the accumulation of PPIX upon ALA induction
in these cells.
The modulation of the basal level of PPIX by the growth-
state of FEK4 cells In order to follow the rate of accumulation
of PPIX under full or low serum conditions in FEK4 cells, we
extracted the PPIX of the cells either in a growing (under full
serum, G3) or every 4 d in a growth-arrested state (low serum
condition). This provided a correlation between the modulation
of the basal level of PPIX and the growth-state of the cells. The
result (Fig 2a) showed that when cells enter the nondividing state
(from day 2 of incubation in low serum, A2), they start gradually
accumulating PPIX and at day 10 of incubation in low serum
(A10), the level is 6-fold higher than in growing cells (G3).
The modulation of the RNA-binding activity of IRP by the
growth state of FEK4 cells The level of free iron can be
estimated in the cells by IRP/IRE bandshift assays. This level was
followed in FEK4 cells under full serum conditions (growing day
3, G3) and under low serum conditions (arrested day 2, A2; day
6, A6; and day 10, A10) in order to demonstrate the relationship
between the modulation of iron levels and the accumulation of
the basal levels of PPIX according to different growth states of the
cells (see Fig 2a). For this purpose the cytoplasmic extracts of cells
in the growing and the growth-arrested states were isolated and
complexed with the H-ferritin IRE probe. The results (Fig 2b)
showed that the level of RNA-protein complexes increased when
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Figure 1. The modulation of PPIX levels by iron-chelation in growing cells and iron supply in growth-arrested cells prior to ALA
treatment. Fold increase in PPIX levels over untreated controls as determined by spectrofluorimeter (see Materials and Methods) in: (a) growing cells
pretreated either with Desferal alone for 6 (Des6 h) and 15 h (Des15 h) or followed by an additional treatment with ALA for 18 h (Des6 h 1 ALA18 h;
Des15 h 1 ALA18 h), treatment of growing cells with ALA alone (ALA18 h) or combined with Desferal for 18 h (ALA/Des18 h) are shown as controls;
(b) growth-arrested cells pretreated either with Fe-citrate 1 (Fe1), 10 (Fe10), and 50 µM (Fe50) alone for 15 h or followed by an additional treatment
with ALA for 18 h (Fe 1 ALA). Treatment of growth-arrested cells with ALA alone for 18 h is used as a control (ALA). For parts (a) and (b) the columns
indicate the mean of three independent experiments. Scale bars: SEM. (c) Modulation of the IRP activity in growing cells (G3) following treatment with
Desferal for 6 h (G3 Des 6 h) or 15 h (G3 Des 15 h). The level of IRP activity in the corresponding growth-arrested cells (A10) is included for
comparison. (d) Modulation of the IRP activity in growth-arrested cells (A10) following treatment with 1 (A10 Fe1), 10 (A10 Fe10), and 50 µM Fe-
citrate (A10 Fe50) for 15 h. The level of IRP activity in the corresponding growing cells (G3) is included for comparison. In (c) and (d) the position of
IRP/IRE complexes are indicated.
Figure 2. Modulation of the basal level of PPIX and IRP/IRE
binding activity in growing and growth-arrested cells. (a)
Determination of the basal level concentration of PPIX in growing and
growth-arrested FEK4 cells as determined by spectrofluorimetry (see
Materials and Methods). Porphyrins were extracted out of FEK4 cells either
grown for 3 d in full serum conditions (G3, growing cells) or incubated
for an additional 2, 6, and 10 d in low serum conditions (A2, A6, A10;
growth-arrested cells). The columns indicate the mean of eight independent
experiments. Scale bars: SEM. (b) Relative increase in IRP binding activity
of growing (G3) and growth-arrested (A2, A6, A10) FEK4 cell extracts as
described in Materials and Methods. P represents the free IRE probe that
was not digested with RNase T1. The positions of the IRP/IRE complexes
are indicated.
cells entered the nondividing state. The value obtained from
scanning of the IRP/IRE signal at day 3 of growing (G3, 80%
confluence, exponentially growing) was arbitrarily chosen as 1.
This value increased up to 1.5-fold at day 2 (A2) and to 3.6 at day
6 (A6) of incubation in low serum. G3 cells incubated for longer
periods in low serum conditions showed an increase of up to 6-
fold at day 10 (A10). These experiments confirm that the level of
available free iron in cells in the exponentially growing state (G3)
is much higher than in cells in the nondividing state (A2→A10)
and is consistent with the hypothesis that this change in available
iron corresponding with growth state of the cells determines the
rate of PPIX accumulation in the cells (Fig 2a).
Similarly, IRP activity increased in the growing cells pretreated
with Desferal as a result of scavenging the intracellular free
iron pool (Fig 1c), and consequently led to an increased PPIX
accumulation following ALA treatment (Fig 1a). Conversely, IRP
activity that decreased in a dose-dependent manner in growth-
arrested cells pretreated with increased concentrations of Fe-citrate
(Fig 1d), led to a dose-dependent decrease in PPIX levels following
ALA treatment (Fig 1b). These results further strengthen the
conclusion that the modulation of IRP binding activity, which
correlates directly with the level of intracellular iron, will determine
the effectiveness of ALA in inducing PPIX in the cells.
Effect of UVA (320–380 nm) on growing and growth-arrested
FEK4 cells treated with ALA In order to establish a correlation
between PPIX accumulation and photokilling by UVA in cells
treated with ALA alone or combined with Desferal, we used the
MTT assay and a clone forming ability assay. The MTT assay
monitors the integrity of mitochondrial membranes. Growing and
growth-arrested FEK4 cells were treated for 18 h with ALA
(100 µM) alone, Desferal (100 µM) alone, or their combinations,
and irradiated with UVA at 10, 20, or 50 kJ per m2. The MTT
assay was performed every 4 h up to 28 h. The percentage of
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Figure 3. PPIX accumulation and
ALA/PDT using MTT assay.
Percentage of viable (a) growing or (b)
growth-arrested FEK4 cells using the MTT
assay (see Materials and Methods) at a series
of UVA (364 nm) fluences. Briefly, FEK4
cells either (a) grown for 3 d in full serum
conditions or (b) incubated for further 10 d
in low serum conditions were first treated
with 100 µM ALA alone (ALA), Desferal
alone (Desferal), or their combination
(ALA/Desferal) and then irradiated at 10,
20, or 50 kJ UVA (364 nm) per m2 fluences.
The columns reflect the mean of three
independent experiments in which three
plates per dose were measured. Scale bars:
SEM.
Figure 4. PPIX accumulation and
ALA/PDT using clone forming ability
assay. The inactivation of clone-forming
ability of (a) growing or (b) growth-arrested
FEK4 cells at a series of UVA (364 nm)
fluences. Briefly, FEK4 cells either (a)
grown for 3 d in full serum conditions or
(b) incubated for a further 10 d in low serum
conditions were treated with 100 µM ALA
alone (ALA), Desferal alone (Desferal), or
their combination (ALA/Desferal) for 18 h
prior to irradiation at 10, 20, or 50 kJ UVA
(364 nm) per m2 fluences. The plots reflect
the mean of three experiments in which
three plates per dilution and per fluence
were counted. Scale bars: SEM.
killing in cells treated with ALA increased gradually up to 18 h
post-irradiation and then reached a plateau (result not shown).
Figure 3 shows the percentage of viable cells obtained 18 h after
irradiation. The percentage of viable cells remaining following
treatment of sham-irradiated growing and of growth-arrested cells
with ALA, Desferal, or their combinations varied between 97%
and 100% (compared with sham-irradiated untreated controls,
results not shown). Irradiation of growing cells 6 Desferal did not
affect the viability of cells (98%–100% viable cells); however, UVA
irradiation of ALA-treated growing cells decreased the viability of
cells in a dose-dependent manner up to around 58% at 50 kJ per
m2 (Fig 3a), and when ALA treatment was combined with Desferal
prior to irradiation this percentage decreased considerably to around
3% at 50 kJ per m2. In growth-arrested cells, the UVA irradiation
of cells without drug treatment was capable of decreasing the
percentage of viable cells up to 50% at 50 kJ per m2 (Fig 3b). The
latter results confirmed a direct correlation between higher basal
level concentration of PPIX and lower survival of growth-arrested
cells upon UVA. The fraction of cells surviving after UVA irradiation
of Desferal-treated growth-arrested cells was comparable with that
of irradiated control cells (50% survival at 50 kJ per m2); however,
when these cells were treated with ALA alone or combined
with Desferal, prior to irradiation, the percentage of cell survival
decreased dramatically (Fig 3b, 0.3% at highest fluence of 50 kJ per
m2). The results obtained from the MTT assay revealed that the
percentage of viable cells was generally higher in growing cells
than in growth-arrested cells. These percentages correlated directly
with the level of accumulation of PPIX in the cells.
In order to confirm the results with the MTT assay, we performed
survival assays based on the formation of colonies by dividing cells
scored 2 wk after UVA irradiation of cells treated with ALA. The
results are illustrated in Fig 4. The irradiation of growing cells
(Fig 4a) 6 Desferal did not affect the viability of cells, whereas
following ALA treatment the survival decreased to moderate levels.
The percentage of survival in growth-arrested cells (Fig 4b) was
lower than in growing cells, in agreement with the MTT assay
where almost no cells survived at fluences of 20 and 50 kJ per m2.
DISCUSSION
Because human skin tumors are one of the potential targets for
both photodetection and phototherapy, particularly using accumula-
tion of endogenous PPIX, we have used the primary cultured
human skin fibroblast cell line, FEK4, as the test system to study
the mechanism of accumulation of PPIX in ALA treatment.
Prior to these studies, our laboratory had already accumulated a
considerable amount of information concerning the basic photobiol-
ogic properties of these cells (with or without sensitizers) as well
as various aspects of the biochemistry and molecular biology of the
metabolism of heme (see Tyrrell et al 1991, 1996).
Our results indicate that the PPIX accumulation following
treatment of the FEK4 cell line with ALA is primarily related to
the level of the free iron pool, which in turn is modulated according
to the growth state of the cell. The importance of available iron
on PPIX production was demonstrated in our study using the iron
chelator Desferal, which reduces the level of available iron pool in
the cells. In growing cells, where there is an adequate level of free
iron, the ALA treatment alone was not efficient in boosting the
level of PPIX, whereas the combination of ALA with Desferal
increased considerably this level up to 47-fold above the control
value. In growth-arrested cells, where the level of free iron is
limited, ALA alone or combined with Desferal boosted the level
of PPIX moderately from 34- to 42-fold above control values.
Our work, however, suggests that even without external manipula-
tions of the iron, intracellular variation in the free iron pool plays
a significant role in ALA/PDT, because the level of photo-damage
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that occurred following UVA irradiation of treated cells was
proportional to the level of accumulation of PPIX. Nevertheless
the percentage of survival was lower in the clone forming ability
assay than the MTT assay. One explanation could be that the
formation of reactive oxygen species as a result of the interaction
of UVA irradiation with PPIX, will cause further damage to the
cells including the peroxidation of cellular membrane lipids. This
in turn will increase the mortality of the cells after 24 h. As a
complementary approach, we used IRP/IRE bandshift assays to
estimate the level of free iron in the cells under various treatment
conditions. These assays clearly demonstrated that the concentration
of the free iron pool is generally higher in growing cells. When
these cells enter the nondividing state, the IRP activation increases
gradually in parallel with the PPIX accumulation. As a result, the
level of activation of IRP is generally higher in growth-arrested than
in growing cells, and this reflects the higher level of accumulation of
PPIX in growth-arrested cells. We therefore propose that the IRP/
IRE bandshift assay would be an ideal test system to screen cells
and tissues for their potential susceptibility to ALA/PDT.
Although the growth-arrest in this study was provoked by
incubation of cells in low serum, a parameter that will not exist in
real tissues, we were able to find a direct correlation between high
level of PPIX and high level of IRP activation due to low level
of available free iron. Similarly, Mu¨llner et al (1992) have found
that growth-arrest of exponentially growing mouse 3T6 fibroblasts
by low serum, increased the IRP activity up to 7-fold with a peak
at 18 h. Based on the supposition that lack of diferric transferrin
rather than growth-arrest of 3T6 cells was responsible for IRP
activation, however, they studied the possible alteration of IRP
activation by sodium butyrate treatment (which blocks the cells in
the G1 phase of the cell cycle) in the presence of normal serum.
The latter treatment did not alter the level of IRP activity in their
system. Furthermore, addition of ferric ammonium citrate or
diferric transferrin to 3T6 cells after 18 h of low serum conditions
reversed the transient rise in IRP activity. They concluded that
during growth-arrest by low serum, IRP is increased because iron-
loaded transferrin becomes limiting in the culture medium, and
this is overcome by the addition of iron salts. Our results are
entirely consistent with this hypothesis and support the idea that
preferential accumulation of PPIX in cells incubated in low serum
is mostly related to the amount of available iron (presumably via
lack of diferric transferrin) rather than the growth state of the cells.
In an independent study in this laboratory (Pourzand C, unpublished
data, 1997), however, using the IRP/IRE bandshift assay, we were
able to demonstrate that the level of free iron pool after 3 d of
exponential growth (G3, 80% confluence, dividing phase) in full
serum conditions, is lower than day 2 (G2, 60% confluence,
exponential dividing phase) and higher than day 4 (G4, 100%
confluent, growth-arrested), consistent with the fact that iron is
consumed by several active processes during cell growth. In the
latter study the basal level of PPIX was also slightly higher in G4
cells (up to 1.7-fold) when compared with G2 cells.
The correlation between growth state of the cells and availability
of iron in modulating the level of PPIX upon addition of exogenous
ALA has also recently been examined by Rittenhouse-Diakun et al
(1995). They demonstrated that stimulation of human peripheral
blood lymphocytes with mitogens such as phytohemagglutinin A
prior to incubation with ALA, results in PPIX accumulation
correlating with their level of activation. They proposed that
activated CD711 cells are selective targets for ALA/PDT because
cells with high expression of CD71 transferrin receptors generate
more PPIX than those with low CD71 expression. They argued that
activated lymphocytes (CD711) would preferentially accumulate
PPIX because of their lower intracellular iron levels and because
of competition for iron between ALA-induced heme production
and cellular growth processes. Furthermore in a more recent study
using four-color flow cytometry (Hryhorenko et al, 1998), they
examined ALA-induced PPIX levels in T cell subsets of resting
and activated (via stimulation by phytohemagglutinin) human
peripheral blood mononuclear cells and the relationship between
CD71 and PPIX. They showed that activated cells preferentially
accumulate endogenous PPIX upon ALA administration and that
the majority of the activated cells were killed following ALA/PDT;
however, the resting cells were spared. Although such a direct
correlation between high expression of TfR in activated T lympho-
cytes and accumulation of PPIX seems to be related to the growth-
state of cells, Pelosi et al (1986) have previously shown that
expression of transferrin receptors in mitogen-activated T lympho-
cytes is specifically modulated by their intracellular iron level, rather
than their proliferation rate. A similar mechanism was also postulated
for leukemic lines by Testa (1985). Also, Neckers and Cossman
(1983) have demonstrated that the TfR induction in mitogen-
stimulated human T lymphocytes that is required for DNA synthesis
and cell division is regulated by interleukin 2. Therefore it seems
that a direct correlation between the induction of TfR in mitogen-
activated T cells and the proliferation rate does not exist. Further-
more, a correlation between TfR expression and PPIX accumula-
tion has not been well established in a variety of malignancies,
because some malignant cell lines may have elevated TfR expression
that is unrelated to their internal iron stores (Neckers, 1991).
The modulatory parameters include interleukin-2, interleukin-6,
calcium channels, cyclic nucleotides, phorbolesters, and viruses.
The fact that the number of transferrin receptors also varies
according to cell type (Iacopetta et al, 1982; Ku¨hn et al, 1990),
makes the CD71 receptor system difficult to use as a general marker
for cells of different origin.
We propose that the level of IRP activation is a better PDT
marker than TfR expression because it directly correlates with the
level of the intracellular pool of available iron. This study encourages
the further investigation of IRP activation as a marker for the
identification of cells or tissues that could serve as targets of PDT
photokilling. Higher levels of IRP binding (reflecting higher
accumulation of PPIX) in neoplastic tissues compared with sur-
rounding normal tissue could help to target cancerous tissue more
precisely and lead to improved selective photodynamic destruction
of neoplastic microlesions. This will require a study of the behavior
of this marker in a variety of malignant tumors of different origin.
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